The 31-GEP Stratifies Risk of Death in Patients with Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study. (2025). SKIN The Journal of Cutaneous Medicine, 9(4), s586. https://doi.org/10.25251/ys9mt689